Trial Details
TERMINATEDBasic Information
| Clinical ID | c1280 |
|---|---|
| Identifier | NCT05479058 |
| Trial Title | A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Filgotinib|DRUG: Placebo |
Participant Information
| Sponsor | Galapagos NV |
|---|---|
| City | Miami |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2022-07-26 |
|---|---|
| Primary Completion Date | 2023-10-09 |
| Completion Date | 2023-10-09 |